EP Patent

EP2139452B1 — Polyaphron topical composition with vitamin d and corticosteroid

Assigned to MC2 Therapeutics Ltd · Expires 2011-07-20 · 15y expired

What this patent protects

A composition suitable for topical application comprising a continuous phase and at least one discontinuous phase, said composition comprising at least one polyaphron dispersion, at least one vitamin D or vitamin D analogue and at least one corticosteroid.

USPTO Abstract

A composition suitable for topical application comprising a continuous phase and at least one discontinuous phase, said composition comprising at least one polyaphron dispersion, at least one vitamin D or vitamin D analogue and at least one corticosteroid.

Drugs covered by this patent

Patent Metadata

Patent number
EP2139452B1
Jurisdiction
EP
Classification
—
Expires
2011-07-20
Drug substance claim
No
Drug product claim
No
Assignee
MC2 Therapeutics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.